[Neuroleptic malignant syndrome].
Charra
B
B
Nejmi
H
H
Hachimi
A
A
Benslama
A
A
Motaouakkil
S
S
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000627:therapeutic use; D003128:Coma / Q000209:etiology; D003131:Combined Modality Therapy; D017679:Cryotherapy; D004359:Drug Therapy, Combination; D005440:Fluid Therapy; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000008:administration & dosage / Q000009:adverse effects*; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D008728:Methotrimeprazine; D006220:Haloperidol